Tptx market cap
SpletResearch Turning Point Therapeutics (TPTX) stock. Get 20 year charts on every key metric for TPTX. Is Turning Point Therapeutics stock a buy or sell? 100% free analysis on TPTX, … SpletToday's Turning Point Therapeutics Inc Share Price - Explore TPTX stock Information, latest price chart, peers growth, market trend and start investing with Scripbox. ... Market Cap. …
Tptx market cap
Did you know?
Splet31. avg. 2024 · Turning Point Therapeutics Announces Scientific Advisory Board SAN DIEGO, Aug. 31, 2024 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ:TPTX), a precision oncology company developing ... SpletTurning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of existing cancer therapies. The company's lead drug candidate, repotrectinib, is a next-generation kinase inhibitor targeting the ROS1 and TRK oncogenic drivers of non-small cell lung …
Splet27. feb. 2024 · Turning Point Therapeutics, Inc. (TPTX) share price prediction for 2024, 2024, 2025, 2026 and 2027. TPTX one year forecast. Turning Point Therapeutics stock … SpletView the real-time Turning Point Therapeutics Inc (%EXCHANGE_SYMBOL% TPTX) share price and assess historical data, charts, technical analysis and the share chat forum. Download the App More markets insights, more alerts, more ways to customise assets watchlists only on the App
SpletThe chart shows the growth of $10,000 invested in Turning Point Therapeutics, Inc. in Apr 2024 and compares it to the S&P 500 index or another benchmark. It would be worth … SpletThe chart shows the growth of $10,000 invested in Turning Point Therapeutics, Inc. in Apr 2024 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $26,301 for a total return of roughly 163.01%.All prices are adjusted for splits and dividends.
SpletUnlock the Power of Big Data with the Next Generation of Investment Analysis Tools
SpletGet the latest Turning Point Therapeutics Inc (NSD:TPTX) stock history quote, stock news, stock price, analyst ratings, earnings, financials, forecast, dividend and ratios at Stock Target Advisor michael cummins arrestSpletHistorical TPTX Price Data Turning Point Therapeutics Description Turning Point Therapeutics Inc is a clinical-stage biopharmaceutical company involved in designing and developing molecule,... michael cummins limitedhttp://analytics.dkv.global/Publicly-Traded-Longevity-Focused-Companies.pdf michael cummins cibcSpletThe historical data and Price History for Turning Point Therapeutics Inc (TPTX) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download. ... Fundamental View: Available only on equity pages, shows Symbol, Name, Market Cap, P/E Ratio (trailing 12 months). Earnings Per Share (trailing 12 months), Net Income, Beta, Annual ... how to change clickfunnels urlSpletThe Investor Relations website contains information about Turning Point Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. michael cummings murders tennesseeSpletGet real-time Turning Point Therapeutics (TPTX) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing. how to change clicker iconSpletProShare Advisors LLC Sells 3,250 Shares of Turning Point Therapeutics, Inc. (NASDAQ:TPTX) ProShare Advisors LLC reduced its position in Turning Point … michael cummings obituary